Pliant Therapeutics, Inc.
PLRX· Nasdaq
Released Nov 10, 2020, after the close
10-Q filed Nov 10, 2020, 41 days after period end · 0001564590-20-052990
| Metric | Q3 2020 | Q3 2019 |
|---|---|---|
| Revenue | $4.81M | — |
| Net Income | -$16.53M | -$13.26M |
| EPS Diluted | -$0.47 | -$8.53 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Pliant Therapeutics, Inc. · CIK 1746473 · Engraved from SEC EDGAR
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
ended Sep 30, 2020 · filed Nov 10, 2020 · 41 d after period end
+15.6% from the close of Nov 6, 2020 to the close of Nov 11, 2020, the first after the release.